The present invention relates to truncated EGF receptor molecules that exhibit increased binding affinities for EGFR ligands such as EGF and TGF-. The present invention also relates to methods of screening for EGF receptor ligands and methods of treatment which involve the use of these molecules.

 
Web www.patentalert.com

< Systems and methods for blood glucose sensing

< Lipoprotein-regulating medicaments

> Nanoporous membrane reactor for miniaturized reactions and enhanced reaction kinetics

> Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
~ 00208